Estimaciones de analistas de Wall Street para Fonar Corp. (FONR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-05-11 | $0.24 | ||
| 2026-02-13 | $0.31 | ||
| 2025-11-10 | $0.34 | ||
| 2025-09-22 | $0.11 | ||
| 2025-05-15 | $0.37 | ||
| 2025-02-19 | $0.29 | ||
| 2024-11-12 | $0.46 | ||
| 2024-09-27 | $0.13 |
Ratios de valoración
| Ratio P/E | 18.90 |
| Precio / Valor contable | 0.66 |
| EV / EBITDA | 6.47 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $73.4M | $78.0M | $81.5M | $87.2M | $85.7M | $89.9M | $97.6M | $98.6M | $102.9M | $104.4M |
| Coste de Ventas | $38.9M | $38.1M | $42.0M | $44.0M | $43.3M | $46.5M | $50.6M | $52.9M | $57.7M | $61.4M |
| Beneficio Bruto | $34.5M | $40.0M | $39.6M | $43.2M | $42.4M | $43.5M | $47.0M | $45.7M | $45.1M | $42.9M |
| I+D | $1.6M | $1.5M | $1.8M | $1.8M | $2.0M | $1.6M | $1.5M | $1.6M | $1.7M | $1.6M |
| Generales y Administrativos | $18.7M | $19.4M | $18.1M | $19.3M | 0 | 0 | 0 | $29.4M | 0 | $29.7M |
| Gastos Operativos | $20.1M | $20.9M | $19.9M | $21.1M | $28.7M | $26.4M | $25.0M | $31.0M | $28.6M | $31.3M |
| Beneficio Operativo | $14.4M | $19.1M | $19.7M | $22.1M | $13.7M | $17.1M | $22.0M | $14.8M | $16.5M | $11.6M |
| EBITDA | $18.1M | $22.6M | $23.8M | $26.5M | $17.6M | $22.0M | $27.7M | $24.6M | $23.9M | $18.5M |
| Gastos por Intereses | $262193 | 0 | $160074 | $98636 | $74321 | $248665 | $346552 | $50131 | $76997 | $25611 |
| Beneficio Antes de Impuestos | $14.5M | $19.3M | $19.8M | $22.5M | $14.1M | $17.7M | $22.8M | $15.8M | $19.3M | $13.8M |
| Impuestos | -$4.3M | -$4.4M | -$5.7M | $2.0M | $2.4M | $4.0M | $5.5M | $3.6M | $5.2M | $3.1M |
| Beneficio Neto | $15.7M | $19.6M | $21.2M | $15.3M | $8.2M | $10.2M | $12.4M | $9.4M | $10.6M | $8.3M |
| BPA | $2.43 | $2.98 | $3.38 | $3.18 | $1.79 | $1.47 | $1.78 | $1.35 | $1.56 | $1.26 |
| BPA Diluido | $2.38 | $2.92 | $3.31 | $3.11 | $1.75 | $1.45 | $1.75 | $1.32 | $1.53 | $1.23 |
| Acciones en Circulación (Diluidas) | $6.6M | $6.7M | $6.4M | $6.6M | $6.7M | $6.7M | $6.7M | $6.8M | $6.5M | $6.6M |
Precio
| Precio | $19.09 |
| Capitalización | $118M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: APYX · ARTV · EDAP · HYPR · IFRX · LUNG · NSPR
Explorar sector: Healthcare · Medical - Equipment & Services
Más secciones de FONR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones